28189628|t|Perlecan and vascular endothelial growth factor - encoding DNA - loaded chitosan scaffolds promote angiogenesis and wound healing
28189628|a|The repair of dermal wounds, particularly in the diabetic population, poses a significant healthcare burden. The impaired wound healing of diabetic wounds is attributed to low levels of endogenous growth factors, including vascular endothelial growth factor (VEGF), that normally stimulate multiple phases of wound healing. In this study, chitosan scaffolds were prepared via freeze drying and loaded with plasmid DNA encoding perlecan domain I and VEGF189 and analyzed in vivo for their ability to promote dermal wound healing. The plasmid DNA encoding perlecan domain I and VEGF189 loaded scaffolds promoted dermal wound healing in normal and diabetic rats. This treatment resulted in an increase in the number of blood vessels and sub-epithelial connective tissue matrix components within the wound beds compared to wounds treated with chitosan scaffolds containing control DNA or wounded controls. These results suggest that chitosan scaffolds containing plasmid DNA encoding VEGF189 and perlecan domain I have the potential to induce angiogenesis and wound healing.
28189628	0	8	Perlecan	T103	UMLS:C0136134
28189628	13	47	vascular endothelial growth factor	T103	UMLS:C1171892
28189628	59	62	DNA	T103	UMLS:C0012854
28189628	72	80	chitosan	T103	UMLS:C0162969
28189628	99	111	angiogenesis	T038	UMLS:C0302600
28189628	116	129	wound healing	T038	UMLS:C0043240
28189628	134	140	repair	T038	UMLS:C0043240
28189628	144	150	dermal	T017	UMLS:C0011646
28189628	151	157	wounds	T037	UMLS:C0043250
28189628	179	187	diabetic	T038	UMLS:C0011847
28189628	188	198	population	T098	UMLS:C1257890
28189628	220	230	healthcare	T058	UMLS:C0086388
28189628	252	265	wound healing	T038	UMLS:C0043240
28189628	269	277	diabetic	T038	UMLS:C0011847
28189628	278	284	wounds	T037	UMLS:C0043250
28189628	327	341	growth factors	T103	UMLS:C0018284
28189628	353	387	vascular endothelial growth factor	T103	UMLS:C1171892
28189628	389	393	VEGF	T103	UMLS:C1171892
28189628	439	452	wound healing	T038	UMLS:C0043240
28189628	462	467	study	T062	UMLS:C2603343
28189628	469	477	chitosan	T103	UMLS:C0162969
28189628	506	519	freeze drying	T058	UMLS:C0016698
28189628	536	543	plasmid	T103	UMLS:C0032136
28189628	544	547	DNA	T103	UMLS:C0012854
28189628	557	565	perlecan	T103	UMLS:C0136134
28189628	566	574	domain I	T082	UMLS:C1514562
28189628	579	586	VEGF189	T103	UMLS:C0376855
28189628	591	599	analyzed	T062	UMLS:C0936012
28189628	637	643	dermal	T017	UMLS:C0011646
28189628	644	657	wound healing	T038	UMLS:C0043240
28189628	663	670	plasmid	T103	UMLS:C0032136
28189628	671	674	DNA	T103	UMLS:C0012854
28189628	684	692	perlecan	T103	UMLS:C0136134
28189628	693	701	domain I	T082	UMLS:C1514562
28189628	706	713	VEGF189	T103	UMLS:C0376855
28189628	740	746	dermal	T017	UMLS:C0011646
28189628	747	760	wound healing	T038	UMLS:C0043240
28189628	775	783	diabetic	T038	UMLS:C0011847
28189628	784	788	rats	T204	UMLS:C0034721
28189628	846	859	blood vessels	T017	UMLS:C0005847
28189628	864	878	sub-epithelial	T017	UMLS:C0014609
28189628	879	903	connective tissue matrix	T017	UMLS:C0230889
28189628	926	936	wound beds	T033	UMLS:C2116804
28189628	949	955	wounds	T037	UMLS:C0043250
28189628	969	977	chitosan	T103	UMLS:C0162969
28189628	1007	1010	DNA	T103	UMLS:C0012854
28189628	1014	1021	wounded	T037	UMLS:C0043250
28189628	1059	1067	chitosan	T103	UMLS:C0162969
28189628	1089	1096	plasmid	T103	UMLS:C0032136
28189628	1097	1100	DNA	T103	UMLS:C0012854
28189628	1110	1117	VEGF189	T103	UMLS:C0376855
28189628	1122	1130	perlecan	T103	UMLS:C0136134
28189628	1131	1139	domain I	T082	UMLS:C1514562
28189628	1169	1181	angiogenesis	T038	UMLS:C0302600
28189628	1186	1199	wound healing	T038	UMLS:C0043240